Home
NSE: PFIZER
ISIN
NSE: PFIZER
Share Price
1M
1Y
3Y
5Y
Date | Price (₹) |
---|---|
04 Feb 2025 | 4424.25 |
03 Feb 2025 | 4510 |
01 Feb 2025 | 4555.4 |
31 Jan 2025 | 4536.05 |
30 Jan 2025 | 4516.55 |
29 Jan 2025 | 4479.9 |
28 Jan 2025 | 4425.4 |
27 Jan 2025 | 4597.3 |
24 Jan 2025 | 4710.85 |
23 Jan 2025 | 4775.75 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Pfizer Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Net Profit of Pfizer Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Pfizer announced that the Annual General Meeting (AGM) of the company will be held on 28 August 2024
Read more
10 Aug 24
Pfizer has fixed 21 August 2024 as record date for payment of dividend. Powered by Capital Market -
Read more
08 Aug 24
Pfizer will hold a meeting of the Board of Directors of the Company on 28 October 2024. Powered by C
Read more
22 Oct 24
On standalone basis Quarter ended September 2024 compared with Quarter ended September 2023. Net sal
Read more
29 Oct 24